Search - Université de Rennes Access content directly

Filter your results

6 Results
authFullName_s : Christophe Hézode
Image document

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Christophe Hézode , Hélène Fontaine , Céline Dorival , Fabien Zoulim , Dominique Larrey et al.
Gastroenterology, 2014, 147 (1), pp.132-142.e4. ⟨10.1053/j.gastro.2014.03.051⟩
Journal articles inserm-01057763v1

Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study)

Victor De Ledinghen , Claire Laforest , Christophe Hézode , Stanislas Pol , Alain Renault et al.
Hepatology, 2017, 64 (6), pp.1130A--1130A
Journal articles hal-01487921v1
Image document

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

Stanislas Pol , Marc Bourlière , Sandy Lucier , Christophe Hézode , Céline Dorival et al.
Journal of Hepatology, 2017, 66 (1), pp.39-47. ⟨10.1016/j.jhep.2016.08.021⟩
Journal articles hal-01435007v1

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

Marc Bourlière , Jean-Pierre Bronowicki , Victor de Ledinghen , Christophe Hézode , Fabien Zoulim et al.
The Lancet Infectious Diseases, 2015, 15 (4), pp.397-404. ⟨10.1016/S1473-3099(15)70050-2⟩
Journal articles hal-01134440v1

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Christophe Hézode , Hélène Fontaine , Céline Dorival , Dominique Larrey , Fabien Zoulim et al.
Journal of Hepatology, 2013, 59 (3), pp.434 - 441. ⟨10.1016/j.jhep.2013.04.035⟩
Journal articles hal-01708037v1

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

Christophe Hézode , Victor De Ledinghen , Hélène Fontaine , Fabien Zoulim , Pascal Lebray et al.
Hepatology, 2015, 62, pp.314A--314A. ⟨10.1002/hep.28160⟩
Journal articles hal-01380169v1